MOMA Therapeutics Funding & Investors
Cambridge, MA
MOMA Therapeutics operates as a biotechnology company. MOMA Therapeutics discover the next generation of precision medicines by targeting the molecular machines that underlie human disease.
momatx.comTotal Amount Raised: $236,000,000
MOMA Therapeutics Funding Rounds
Series B
$150,000,000
Series B Investors
Goldman Sachs Asset ManagementThird Rock VenturesSection 32Casdin CapitalInvusCormorant Asset ManagementAlexandria Venture InvestmentsRock Springs CapitalNextech InvestCreacion VenturesPavilion CapitalLifeSci Venture PartnersCurie.BioSeries A
$86,000,000
Series A Investors
Third Rock VenturesNextech InvestCasdin CapitalCormorant Asset ManagementRock Springs CapitalAlexandria Venture InvestmentsCreacion Ventures
Funding info provided by Diffbot.